Poncelet et al. [6] investigated MVD in uterine leiomyosarcoma using antibodies against von Willebrand factor, CD34, and CD31 and concluded that MVD assessed only with antibodies against von Willebrand factor has prognostic value in this type of malignancy. Here, PECAM1 is linked to leiomyosarcoma.